Liang et al. noted the potential for p.L747P and p.L747S EGFR mutations to be misclassified as a 19DEL mutation using the above methods due to poor DNA quality or less-than-ideal specimens lacking a large enough proportion of tumor cells [93]. The gene discussed is EGFR; the disease is neoplasm.